Today, at the 2011 European Multidisciplinary Cancer Congress, two new risk indicators for prostate cancer will be revealed. The investigation, led by Dr David Orsted at the Copenhagen University Hospital, Herlev, reveals that men who are diagnosed with benign prostate enlargement have a higher risk of developing and dying from prostate cancer. The second investigation reveals that the long-term risk of healthy men developing and dying from this disease can be predicted by monitoring prostate-specific antigen levels...
More...
More...